Less mesh, less dissection, same tension-free support130
With GYNECARE TVT ABBREVO® Continence System you can be confident that you are delivering consistent efficacy with less mesh. It provides excellent tension-free support with just 12 cm of mesh. It uses less mesh in the thigh muscles. That means that 84% less mesh is placed in adductor muscles and 38% less mesh overall.120,130
Like a full length obturator sling, GYNECARE TVT ABBREVO® provides sufficient support with the symmetrical bilateral placement of a 12-cm mesh, which reaches 3 key anatomical structures: obturator internus, obturator membrane and obturator externus.130
GYNECARE TVT ABBREVO® is a 12cm transobturator mid-urethral sling used for the treatment of female stress urinary incontinence.
Looking for more specific instruction regarding our devices? Here are various materials and media to explain and walk you through the proper steps for their use. For the full steps to use of any of our devices, please refer to the package insert.
GYNECARE TVT ABBREVO® Continence System offers the same efficacy with less mesh. In a randomized, controlled trial, a modified obturator procedure with a shorter mesh, which is similar to GYNECARE TVT ABBREVO®, delivered the same consistent efficacy as the full length GYNECARE TVT™ Obturator System Tension-free Support for Incontinence*120
Significantly less post-operative pain*
Patients in the Modified GYNECARE TVT Obturator System group had:†120
Significantly lower incidence and intensity of groin pain on day 0 and day 1.
35% fewer patients experienced groin pain immediately after surgery.
At year three no severe groin pain was reported in either group.152
* Demonstrated in a 36-month, single-center randomized, single-blinded prospective trial of 175 women suffering from SUI. They were randomized to GYNECARE TVT Obturator System or a version modified to use a shorter mesh and less dissection. Evaluation included urinary symptoms and QoL questionnaires. Primary outcome measure was the disappearance of subjective and objective SUI at one year. Secondary outcome measures included complication rates and severity of postoperative groin pain assessed using a visual analog scale.
† Pain was assessed using a visual analog scale (VAS) graded from 0 to 10; 0 corresponds to absence of pain, 10 corresponds to the worst pain. Severe groin pain was defined as VAS≥5. The patients that reported groin pain at 1 year had VAS scores ≤3 in all cases.)
This link will take you to a website to which Ethicon privacy policy does not apply
We encourage you to visit the privacy policy of every website before you visit
